New Product: Cuprior (trientine tetrahydrochloride) 150 mg film-coated tablets

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
12 April 2019

Abstract

Trientine is a copper-chelating agent licensed for the treatment of Wilson's disease in adults, adolescents and children aged = 5 years intolerant to D-penicillamine therapy.